AI Verdict
IMCR has stronger fundamentals based on our AI analysis.
IMRX vs IMCR Fundamental Comparison
| Metric | IMRX | IMCR |
|---|---|---|
| Revenue | $0.0 | $400.0M |
| Net Income | $-56.0M | $-35.5M |
| Net Margin | N/A | -8.9% |
| ROE | -25.6% | -9.3% |
| ROA | -24.2% | -3.3% |
| Current Ratio | 17.50x | 4.04x |
| Debt/Equity | 0.00x | 1.15x |
| EPS | $-1.27 | $-0.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMRX vs IMCR: Frequently Asked Questions
Is IMRX or IMCR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMCR has stronger fundamentals. IMRX is rated SELL (72% confidence) while IMCR is rated HOLD (65% confidence). This is not investment advice.
How does IMRX compare to IMCR fundamentally?
Immuneering Corp has ROE of -25.6% vs Immunocore Holdings plc's -9.3%. Net margins are N/A vs -8.9% respectively.
Which stock pays higher dividends, IMRX or IMCR?
IMRX has a dividend yield of N/A or no dividend while IMCR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMRX or IMCR for long term?
For long-term investing, consider that IMRX has SELL rating with 72% confidence, while IMCR has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMRX vs IMCR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMRX vs IMCR, the AI consensus favors IMCR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.